Glen Eagle Advisors’s Tenet Healthcare THC Stock Holding History

Glen Eagle Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7K	Hold	100	–	–	﹤0.01%	602
2026 Q1	$18.9K	Hold	100	–	–	﹤0.01%	575
2025 Q4	$19.9K	Hold	100	–	–	﹤0.01%	584
2025 Q3	$20.3K	Hold	100	–	–	﹤0.01%	574
2025 Q2	$17.6K	Hold	100	–	–	﹤0.01%	574
2025 Q1	$13.4K	Sell	100 -23	-19%	-$3.03K	﹤0.01%	591
2024 Q4	$15.5K	Buy	123 +120	+4,000%	+$17.8K	﹤0.01%	585
2024 Q3	$499	Hold	3	–	–	﹤0.01%	1070
2024 Q2	$399	Hold	3	–	–	﹤0.01%	1075
2024 Q1	$315	Hold	3	–	–	﹤0.01%	1048
2023 Q4	$227	Hold	3	–	–	﹤0.01%	996
2023 Q3	$198	Hold	3	–	–	﹤0.01%	998
2023 Q2	$245	Hold	3	–	–	﹤0.01%	1028
2023 Q1	$178	Buy	+3	New	+$167	﹤0.01%	1038
2018 Q3	–	Sell	-380	Closed	-$12.8K	–	731
2018 Q2	$12.8K	Hold	380	–	–	0.01%	431
2018 Q1	$9.21K	Hold	380	–	–	0.01%	446
2017 Q4	$5.76K	Hold	380	–	–	0.01%	498
2017 Q3	$6.24K	Hold	380	–	–	0.01%	489
2017 Q2	$7.35K	Hold	380	–	–	0.01%	438
2017 Q1	$6.73K	Hold	380	–	–	0.01%	427
2016 Q4	$5.64K	Buy	+380	New	+$6.82K	0.01%	427

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Glen Eagle Advisors's THC Position: Q2 2026 in Review

Glen Eagle Advisors held its Tenet Healthcare (THC) position steady in Q2 2026 at 100 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

Glen Eagle Advisors first reported a position in THC in Q4 2016 and has held it in 21 quarters since. The position peaked at $20.3K in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Glen Eagle Advisors held 100 shares of Tenet Healthcare worth $18.7K as of Q2 2026.
Glen Eagle Advisors left its Tenet Healthcare share count unchanged in Q2 2026.
Tenet Healthcare made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #602 holding.
Glen Eagle Advisors first reported a position in Tenet Healthcare in Q4 2016 and has held it in 21 quarters since.
Glen Eagle Advisors's Tenet Healthcare position peaked at $20.3K in Q3 2025.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.